THERALINK TECHNOLOGIES, INC.

THER

THERALINK TECHNOLOGIES, INC.

THER

Insider Sentiment (TTM):

Last Purchase:2015-05-18Last Sale:2015-09-02Shares Purchased (TTM):0Shares Sold (TTM):0

Institutional Sentiment:

As of:2022-06-30Institutional Shares Owned:67Shares Outstanding:6,062,411,449Institutional Ownership Pct.:0.00%

Earnings Market Reaction:

Filing Date:2024-02-20Price on Filing Date:N/APrevious Close:N/A% Change:N/A

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

10‑Q10‑K

Values in Millions ($)	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31
Assets
Assets Current
Cash	0	1	0	0	1	0	0	0	0	0	0	0	1
Accounts Receivable Net Current	0	0	0	0	0	0	0	0	0	-	0	0	-
Accounts And Other Receivables Net Current	-	-	-	-	-	-	0	0	0	0	0	0	0
Prepaid Expense And Other Assets Current	0	0	0	0	0	0	0	0	0	0	0	0	0
Marketable Securities Current	0	0	0	0	0	0	0	0	0	0	0	0	0
Assets Current	0	1	0	0	1	1	0	1	1	1	1	1	1
Assets Noncurrent
Inventory Raw Materials And Supplies	-	-	-	-	-	-	-	-	0	0	0	0	-
Deferred Costs Current	-	-	-	-	-	-	-	-	-	-	0	-	-
Property Plant And Equipment Net	0	0	0	1	1	1	1	1	1	1	1	1	1
Finance Lease Right Of Use Asset	0	0	0	0	0	0	0	0	0	0	0	0	0
Operating Lease Right Of Use Asset	1	1	1	1	1	1	1	1	1	0	0	0	0
Deferred Costs	-	-	-	-	-	0	-	-	-	-	-	-	-
Security Deposit	0	0	0	0	0	0	0	0	0	0	0	0	0
Assets	2	3	2	2	3	3	2	3	3	2	2	2	2
Liabilities Current
Liabilities And Stockhold…
Accounts Payable Current	-	-	-	-	1	1	1	1	1	1	1	1	1
Accounts Payable Related Parties Current	-	-	-	-	0	0	0	0	0	0	-	-	-
Accrued Liabilities Current	-	-	-	0	0	0	0	0	0	0	0	0	0
Deferred Compensation Liability Current	0	0	0	0	1	0	0	0	0	0	0	0	0
Deferred Revenue Current	-	-	-	-	-	-	-	-	-	0	0	-	-
Employee Related Liabilities Current	0	0	0	0	0	0	0	0	0	0	0	0	0
Deferred Revenue	-	-	-	-	-	-	-	-	-	-	-	0	0
Contract With Customer Liability Current	0	0	0	0	0	0	0	0	0	0	-	-	-
Convertible Debt Current	-	-	-	3	1	-	-	-	-	-	0	-	-
Notes Payable Related Parties Classified Current	-	-	-	-	0	0	0	0	0	0	0	-	-
Notes Payable Current	-	-	-	-	0	0	0	0	0	0	0	0	0
Finance Lease Liability Current	0	0	0	0	0	0	0	0	0	0	0	0	0
Operating Lease Liability Current	0	0	0	0	0	0	0	0	0	0	0	0	0
Accrued Insurance Current	0	0	0	0	0	0	0	0	0	0	-	-	-
Derivative Liabilities Current	29	16	33	45	42	-	-	-	-	-	-	-	-
Business Combination Contingent Consideration Liab…	0	0	0	0	0	0	-	-	-	0	-	-	-
Liabilities Current	58	40	48	53	46	3	2	2	3	3	3	2	1
Liabilities Noncurrent
Other Liabilities Current	-	-	-	-	-	-	0	0	0	0	-	-	-
Finance Lease Liability Noncurrent	-	0	0	0	0	0	0	0	0	0	0	0	0
Operating Lease Liability Noncurrent	1	1	1	1	1	1	1	1	1	0	0	0	0
Liabilities	59	41	49	55	48	6	5	4	5	4	3	3	2
Temporary Equity Carrying Amount Attributable To P…	-	-	-	-	-	-	-	-	-	-	2	2	2
Stockholders Equity
Common Stock Value	1	1	1	1	1	1	1	1	1	1	1	1	1
Convertible Debt Noncurrent	-	-	-	-	-	0	0	0	0	0	-	-	-
Additional Paid In Capital	55	55	55	55	54	55	49	49	46	44	43	42	42
Retained Earnings Accumulated Deficit	-113	-94	-103	-108	-99	-63	-55	-53	-51	-50	-47	-46	-45
Stockholders Equity	-57	-38	-47	-52	-44	-7	-5	-4	-5	-5	-3	-3	-2
Liabilities And Stockholders Equity	2	3	2	2	3	3	2	3	3	2	2	2	2
Preferred Stock Par Or Stated Value Per Share	0	0	0	0	0	0	0	0	0	0	0	0	0
Accounts Receivable Related Parties Current	-	-	-	-	-	0	0	0	0	0	-	-	-
Preferred Stock Shares Authorized	0	0	0	0	0	0	0	0	0	0	0	0	0
Preferred Stock Shares Issued	-	-	-	-	-	-	-	-	-	-	-	0	-
Common Stock Par Or Stated Value Per Share	0	0	0.001	0	0	0	0	0	-	0	0	0	0
Common Stock Shares Authorized	100,000	100,000	100,000	100,000	100,000	100,000	12,000	12,000	-	100,000	12,000	12,000	12,000
Common Stock Shares Issued	6,151	6,151	6,151	6,151	6,151	6,151	6,151	6,026	5,124	5,124	5,124	5,124	5,124
Shares Outstanding	6,151	6,151	6,151	6,151	6,151	6,151	6,151	6,026	5,124	5,124	5,124	5,124	5,124
Preferred Stock Shares Outstanding	-	-	-	-	-	0	-	-	-	0	-	0	-

Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

10‑Q10‑K

0/5

Search a metric to start building a table

Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

10‑Q10‑K

Stock Price:

OnOff

Transformations:

0/1

Search a metric to start building a visual

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

10‑Q10‑K

Fiscal Year	Q1 1 Month	Q1 2 Month	Q1 3 Month	Q3 1 Month	Q3 2 Month	Q3 3 Month	Q4 1 Month	Q4 2 Month	Q4 3 Month
2023	6.25%	50.00%	12.50%	-50.00%	-55.56%	-38.89%	-40.00%	-20.00%	-33.33%
2022	12.50%	-12.50%	10.00%	-17.78%	-24.44%	-26.67%	3.23%	-6.45%	-41.94%
2021	1098.50%	861.30%	911.24%	1098.50%	861.30%	911.24%	-4.55%	24.55%	-80.00%
2020	-	-	-	-19.32%	-60.23%	-60.80%	-	-	-
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial

Subscribe to unlock 17+ years of financial data and 90+ calculated metrics

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Start free trial

Performance and Valuation Metrics

Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.

Metrics	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31
Liquidity Ratios
Current Ratio	0.00	0.03	0.00	0.01	0.03	0.19	0.22	0.40	0.24	0.19	0.26	0.20	0.56
Quick Ratio	0.00	0.03	0.00	0.00	0.03	0.12	0.13	0.28	0.17	0.13	0.21	0.14	0.41
Working Capital	-57.53M	-38.57M	-47.85M	-52.98M	-45.00M	-2.81M	-1.58M	-1.32M	-2.42M	-2.66M	-2.23M	-1.99M	-621.27K
Leverage & Debt
Debt to Equity	-1.03	-1.07	-1.04	-1.04	-1.07	-0.94	-0.88	-0.95	-0.95	-0.72	-0.95	-0.87	-0.97
Interest Coverage TTM	-0.51	-0.64	-1.11	-1.69	-3.75	-6.64	-9.47	-15.12	-32.63	-83.93	-84.88	-120.32	-99.03
Debt Ratio	33.01	14.37	28.53	24.29	14.64	2.46	1.88	1.33	1.68	2.19	1.79	1.73	0.88
Efficiency & Turnover
Asset Turnover TTM	0.31	0.27	0.38	0.29	0.20	0.29	0.20	0.24	0.27	0.23	0.28	0.38	0.23
Days Sales Outstanding TTM	22.11	13.67	29.25	43.95	30.45	19.19	115.32	67.27	28.72	-	56.84	67.09	-
Receivables Turnover TTM	16.51	26.70	12.48	8.31	11.99	19.02	3.17	5.43	12.71	-	6.42	5.44	-
Per Share Metrics
Diluted EPS TTM	-0.01	-0.01	-0.71	-	-0.00	0.00	-0.00	-	-	-	-	-	-
Free Cash Flow Per Share TTM	-0.00	-0.00	-0.00	-0.00	-0.00	-0.00	-0.00	-0.00	-0.00	-0.00	-0.00	-0.00	-0.00
Dividend Per Share TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Margin Metrics
Gross Profit Margin TTM	80.47%	85.36%	74.11%	66.07%	58.79%	55.03%	59.83%	74.36%	76.91%	81.53%	74.56%	73.65%	70.47%
Operating Profit Margin TTM	-1,432.64%	-1,625.07%	-1,847.04%	-1,868.84%	-2,247.22%	-1,964.79%	-1,780.67%	-1,357.12%	-1,095.48%	-1,271.13%	-881.53%	-1,532.58%	-1,658.27%
Net Profit Margin TTM	-5,088.10%	-7,610.76%	-1,938.29%	-2,888.51%	-2,481.76%	3,332.78%	-2,197.19%	-1,613.83%	-1,272.13%	-1,419.24%	-1,248.33%	-2,138.55%	-2,445.68%
Growth Metrics
Net Revenue Growth (1Y)	32.21%	22.39%	89.07%	40.48%	-7.04%	8.59%	-26.92%	70.74%	172.10%	152.97%	639.94%	502.91%	-
Net Income Growth (1Y)	171.05%	-379.50%	66.79%	151.45%	81.34%	-355.00%	28.62%	28.85%	41.53%	-2.43%	12.18%	11.78%	-42.21%
EPS Growth (1Y)	171.05%	-367.22%	64.37%	128.75%	63.77%	-332.82%	17.77%	20.76%	30.55%	-6.89%	-92.15%	-99.98%	-94.42%
Valuation Metrics
P/E TTM	-0.23	-0.10	-1.02	-0.66	-1.43	1.01	-2.69	-229.81	-1,029.71	-33.62	-435.47	-1,220.11	-180.43
P/B TTM	-0.16	-0.15	-0.32	-0.27	-0.47	-3.03	-4.74	-496.97	-1,701.15	-54.29	-889.17	-2,533.31	-579.96
P/S TTM	11.88	7.40	19.82	19.18	35.61	33.68	59.09	3,708.76	13,099.26	477.10	5,436.09	26,092.73	4,412.84
Market Cap	9.23M	5.54M	15.38M	14.15M	20.92M	20.58M	24.25M	1.95B	8.28B	268.48M	3.05B	8.02B	1.02B
Enterprise Value	9.23M	4.57M	15.40M	16.89M	20.54M	20.73M	24.51M	1.95B	8.28B	268.37M	3.05B	8.02B	1.02B
Calculated Values
Free Cash Flow TTM	-8.49M	-9.31M	-7.11M	-8.08M	-6.57M	-6.28M	-6.55M	-5.86M	-6.10M	-5.84M	-5.38M	-5.29M	-4.67M
Net Debt	-301.00	-963.09K	23.43K	2.74M	-377.81K	142.21K	258.92K	-257.13K	-255.81K	-112.06K	82.60K	-90.83K	-374.83K
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
NCAV
NCAV Per Share TTM
Valuation Ratios
P/CF TTM
PEG Ratio
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
EV Revenue TTM
EV FCF TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2015-09-02Sale

Owner: Head, Jonathan Frederick

Title: Chief Executive Officer

Shares: 1,025,000

Price/Share: $0.00

Value: -

Shares Owned: 16,926,078

Relationship: Director,Officer

Ownership: Direct

2015-09-02Sale

Owner: Elliot, Robert Lange Jr

Title: -

Shares: 1,025,000

Price/Share: $0.00

Value: -

Shares Owned: 16,926,079

Relationship: Director,TenPercentOwner

Ownership: Direct

2015-05-18Sale

Owner: Leone, Group, Llc

Title: -

Shares: 17,774,136

Price/Share: $0.00

Value: -

Shares Owned: 132,893,954

Relationship: TenPercentOwner

Ownership: Direct

2015-05-18Purchase

Owner: Dietrich, Constantin

Title: Chief Executive Officer

Shares: 35,548,272

Price/Share: -

Value: -

Shares Owned: 35,848,272

Relationship: Director,Officer

Ownership: Direct

2015-05-18Sale

Owner: American, Capital Venture…

Title: -

Shares: 17,774,136

Price/Share: $0.00

Value: -

Shares Owned: 132,893,954

Relationship: TenPercentOwner

Ownership: Direct

Filed Date	Owner	Relationship	Title	Ownership	Purchase/Sale	No. Shares	Price Per Share	Value	Shares Owned	Document Type
2015-09-02	Head, Jonathan Frederick	Director,Officer	Chief Executive Officer	Direct	Sale	1,025,000	0.00	$0.00	16,926,078	4
2015-09-02	Elliot, Robert Lange Jr	Director,TenPercentOwner	-	Direct	Sale	1,025,000	0.00	$0.00	16,926,079	4
2015-05-18	Leone, Group, Llc	TenPercentOwner	-	Direct	Sale	17,774,136	0.00	$0.00	132,893,954	4
2015-05-18	Dietrich, Constantin	Director,Officer	Chief Executive Officer	Direct	Purchase	35,548,272	-	-	35,848,272	4
2015-05-18	American, Capital Venture…	TenPercentOwner	-	Direct	Sale	17,774,136	0.00	$0.00	132,893,954	4
2015-04-14	Dietrich, Constantin	Director,Officer	Chief Executive Officer	Direct	Purchase	35,548,272	-	-	35,848,272	4
2015-03-10	Dietrich, Constantin	Director,Officer	Chief Executive Officer	Direct	Sale	12,750,000	0.00	$0.00	0	4
2015-03-10	Carusone, Joseph	Director,Officer	VP, Investor Relations#	Direct	Sale	4,200,000	0.00	$0.00	0	4
2015-03-10	Dietrich, Constantin	Director,Officer	Chief Executive Officer	Direct	Purchase	300,000	0.00	$0.00	300,000	4
2013-04-05	Carusone, Joseph, Opex En…	TenPercentOwner	VP, Investor Relations	Indirect	Sale	600,000	0.01	$6,000.00	0	4
2013-04-05	Carusone, Joseph, Opex En…	TenPercentOwner	VP, Investor Relations	Direct	Purchase	1,000,000	0.02	$20,000.00	1,400,000	4
2013-04-05	Dietrich, Constantin	Director,TenPercentOwner	-	Direct	Purchase	4,250,000	0.01	$42,500.00	4,250,000	4
2013-04-05	Durrant, Cameron	Director,Officer,TenPercentOwner	President, CEO, CFO, Treasurer	Direct	Purchase	4,250,000	0.01	$42,500.00	0	4
Additional insider transactions are for subscribers only. Unlock the complete Form 4 filing history Start 7-day free trial

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Institutional Ownership

No data available for chart

2022-06-30

0.00%

Inst. Shares: 67

Shares Outstanding: 6,062,411,449

2022-03-31

0.00%

Inst. Shares: 67

Shares Outstanding: 5,596,220,371

Date	Institutional Shares Owned	Shares Outstanding	Institutional Ownership %
2022-06-30	67	6,062,411,449	0.00%
2022-03-31	67	5,596,220,371	0.00%
Additional institutional holders are for subscribers only. Unlock the complete Form 13F ownership history Start 7-day free trial

THERALINK TECHNOLOGIES, INC. (THER) — SEC Financial Statements & Analysis

THERALINK TECHNOLOGIES, INC. (THER) is a pharmaceutical preparations company, incorporated in NV. THERALINK TECHNOLOGIES, INC. trades on OTC as: THER. Based on its latest SEC filing (Form 10-Q, period ending 2023-12-31), THERALINK TECHNOLOGIES, INC. reported a 32.21% year-over-year revenue growth, a Gross Profit Margin of 80.47% (TTM), a Debt-to-Equity ratio of -1.03x, a Price-to-Sales (P/S) ratio of 11.88x (TTM), a Price-to-Book (P/B) ratio of -0.16x (TTM), at a market cap of $9.23M. Figures below are sourced from SEC EDGAR, as-filed.

Net Revenue TTM Growth 1Y: 32.21%
Gross Profit Margin TTM: 80.47%
Debt To Equity: -1.03x
P/S TTM: 11.88x
P/B TTM: -0.16x
Market Cap: $9.23M

Data as of 2023-12-31 · Source: SEC EDGAR

Frequently Asked Questions

What industry is THERALINK TECHNOLOGIES, INC. in?

THERALINK TECHNOLOGIES, INC. (THER) operates in the Pharmaceutical Preparations industry.

What is THER's market cap?

THERALINK TECHNOLOGIES, INC. (THER) has a market capitalization of $9.23M as of 2023-12-31.

What exchange does THER trade on?

THERALINK TECHNOLOGIES, INC. (THER) trades on the OTC.

Where is THERALINK TECHNOLOGIES, INC. incorporated?

THERALINK TECHNOLOGIES, INC. is incorporated in NV.